Follow-up after treatment with Extracorporeal Membrane Oxygenation (ECMO) at the ECMO Center Karolinska. Patients: adult survivors treated with ECMO for severe refractory respiratory failure at least 5 years earlier. Investigations: brain and pulmonary radiographic morphology, cognitive testing, pulmonary function testing, exercise tolerance, quality of life and mood disorder screening.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of participants with abnormal cognitive functioning assessed by the Wechsler Adult Intelligence Scale and memory tests
Timeframe: 5-17 years after treatment
Number of participants with abnormal brain imaging assessed by magnetic resonance imaging
Timeframe: 5-17 years after treatment
Number of Participants With Abnormal Pulmonary function
Timeframe: 5-17 years after treatment
Number of Participants With Abnormal Lungs radiographic findings assessed by high-resolution CT scan
Timeframe: 5-17 years after treatment
Number of participants with signs of post-traumatic stress assessed by the Trauma Screening Questionnaire
Timeframe: 5-17 years after treatment
Number of participants with signs of a reduced health related quality-of-life, assessed by the Short Form-36
Timeframe: 5-17 years after treatment
Number of participants with signs of a reduced Health related quality-of-life, assessed by the S:t George´s Respiratory Questionnaire
Timeframe: 5-17 years after treatment
Number of participants with signs of a reduced exercise tolerance
Timeframe: 5-17 years after treatment
Number of participants with signs of anxiety and depression assessed by the Hospital and Anxiety Depression Scale
Timeframe: 5-17 years after treatment